429 related articles for article (PubMed ID: 27507047)
1. UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma.
Nakamura K; Baba Y; Kosumi K; Harada K; Shigaki H; Miyake K; Kiyozumi Y; Ohuchi M; Kurashige J; Ishimoto T; Iwatsuki M; Sakamoto Y; Yoshida N; Watanabe M; Nakao M; Baba H
Oncotarget; 2016 Sep; 7(36):57821-57831. PubMed ID: 27507047
[TBL] [Abstract][Full Text] [Related]
2. LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Sakamaki K; Ohashi Y; Baba H
Ann Surg; 2013 Mar; 257(3):449-55. PubMed ID: 23023202
[TBL] [Abstract][Full Text] [Related]
3. LINE-1 hypomethylation, DNA copy number alterations, and CDK6 amplification in esophageal squamous cell carcinoma.
Baba Y; Watanabe M; Murata A; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Sakamaki K; Nakao M; Baba H
Clin Cancer Res; 2014 Mar; 20(5):1114-24. PubMed ID: 24423610
[TBL] [Abstract][Full Text] [Related]
4. Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma.
Zhu J; Ling Y; Xu Y; Lu MZ; Liu YP; Zhang CS
Int J Clin Exp Pathol; 2015; 8(11):14392-400. PubMed ID: 26823755
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal instability associated with global DNA hypomethylation is associated with the initiation and progression of esophageal squamous cell carcinoma.
Kawano H; Saeki H; Kitao H; Tsuda Y; Otsu H; Ando K; Ito S; Egashira A; Oki E; Morita M; Oda Y; Maehara Y
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S696-702. PubMed ID: 24898425
[TBL] [Abstract][Full Text] [Related]
6. LINE-1 hypomethylation in noncancerous esophageal mucosae is associated with smoking history.
Shigaki H; Baba Y; Watanabe M; Iwagami S; Miyake K; Ishimoto T; Iwatsuki M; Baba H
Ann Surg Oncol; 2012 Dec; 19(13):4238-43. PubMed ID: 22766991
[TBL] [Abstract][Full Text] [Related]
7. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma.
Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ida S; Nagai Y; Ishimoto T; Iwatsuki M; Sakamoto Y; Miyamoto Y; Baba H
Ann Surg Oncol; 2012 Aug; 19(8):2726-32. PubMed ID: 22187122
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma.
Yang C; Wang Y; Zhang F; Sun G; Li C; Jing S; Liu Q; Cheng Y
Mol Biol Rep; 2013 Sep; 40(9):5225-35. PubMed ID: 23943380
[TBL] [Abstract][Full Text] [Related]
9.
Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
[TBL] [Abstract][Full Text] [Related]
10. UHRF1 is an Independent Prognostic Factor and a Potential Therapeutic Target of Esophageal Squamous Cell Carcinoma.
Ye J; Zhang Y; Liang W; Huang J; Wang L; Zhong X
J Cancer; 2017; 8(19):4027-4039. PubMed ID: 29187878
[No Abstract] [Full Text] [Related]
11. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
[TBL] [Abstract][Full Text] [Related]
12. Functional dissection of the role of UHRF1 in the regulation of retinoblastoma methylome.
Kan G; He H; Zhao Q; Li X; Li M; Yang H; Kim JK
Oncotarget; 2017 Jun; 8(24):39497-39511. PubMed ID: 28467809
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain 1 promotes bladder cancer progression.
Ying L; Lin J; Qiu F; Cao M; Chen H; Liu Z; Huang Y
FEBS J; 2015 Jan; 282(1):174-82. PubMed ID: 25323766
[TBL] [Abstract][Full Text] [Related]
14. APOBEC3B is an enzymatic source of molecular alterations in esophageal squamous cell carcinoma.
Kosumi K; Baba Y; Ishimoto T; Harada K; Nakamura K; Ohuchi M; Kiyozumi Y; Izumi D; Tokunaga R; Taki K; Higashi T; Miyata T; Shigaki H; Kurashige J; Hiyoshi Y; Iwatsuki M; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
Med Oncol; 2016 Mar; 33(3):26. PubMed ID: 26880326
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylation of Alu repetitive elements in esophageal mucosa, and its potential contribution to the epigenetic field for cancerization.
Matsuda Y; Yamashita S; Lee YC; Niwa T; Yoshida T; Gyobu K; Igaki H; Kushima R; Lee S; Wu MS; Osugi H; Suehiro S; Ushijima T
Cancer Causes Control; 2012 Jun; 23(6):865-73. PubMed ID: 22527164
[TBL] [Abstract][Full Text] [Related]
16.
Goto D; Komeda K; Uwatoko N; Nakashima M; Koike M; Kawai K; Kodama Y; Miyazawa A; Tanaka I; Hase T; Morise M; Hasegawa Y; Kawabe T; Sato M
Cancer Invest; 2020 Apr; 38(4):240-249. PubMed ID: 32212938
[TBL] [Abstract][Full Text] [Related]
17. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
[TBL] [Abstract][Full Text] [Related]
18. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
[TBL] [Abstract][Full Text] [Related]
20. TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma.
Murata A; Baba Y; Ishimoto T; Miyake K; Kosumi K; Harada K; Kurashige J; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Yamamoto M; Oda S; Watanabe M; Nakao M; Baba H
Oncotarget; 2015 Sep; 6(27):23372-82. PubMed ID: 26093090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
